Sander van Asbeck, CEO and co-founder of RiboPro has been elected most promising entrepreneur of the year 2022. With his company, he develops messenger RNA technology for the development of […]
We’re delighted to announce Robin Katoen has joined RiboPro from April 1st as our Chief Marketing Communication Officer. He has a proven track record in digital transformation and bringing innovative […]
RiboPro has won the Blue Tulip Award hosted by Accenture in the Netherlands last week. Formerly known as Accenture Innovation Awards, the annual Blue Tulip Awards identifies the most promising […]
Time flies when you are having fun; it is already a bit more than 1 year that Marc Penders joined RiboPro. As Head of Production, he has coordinated the synthesis […]
Do you like to work with messenger RNA, but not sure how to start? Are you wondering about what experimental parameters to keep an eye on? Then we have a […]
Now mRNA has proven its worth as a vaccination agent, more and more researchers are becoming aware of the benefits of mRNA for vaccination, therapy and research purposes. However, a […]
Silvy is a seasoned executive, with extremely valuable experience in scaling a science-driven start-up, and an experienced scientist as well. From the 1st of May on, she will employ those […]
Recently our founder and CEO, Sander van Asbeck, was interviewed by Jan Taco te Gussinklo for ReportersOnline. In this article, they discussed the role of mRNA in the near and […]
On the second of April 2021, RiboPro is officially 1 year old and that is cause for celebration. Especially, since we started during a difficult time, in which lab-access, funding […]